JPH0742224B2 - Method for producing bath salt containing enzyme - Google Patents

Method for producing bath salt containing enzyme

Info

Publication number
JPH0742224B2
JPH0742224B2 JP60237872A JP23787285A JPH0742224B2 JP H0742224 B2 JPH0742224 B2 JP H0742224B2 JP 60237872 A JP60237872 A JP 60237872A JP 23787285 A JP23787285 A JP 23787285A JP H0742224 B2 JPH0742224 B2 JP H0742224B2
Authority
JP
Japan
Prior art keywords
enzyme
origin
granulated
plant
enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP60237872A
Other languages
Japanese (ja)
Other versions
JPS6296413A (en
Inventor
忠生 白石
Original Assignee
忠生 白石
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 忠生 白石 filed Critical 忠生 白石
Priority to JP60237872A priority Critical patent/JPH0742224B2/en
Publication of JPS6296413A publication Critical patent/JPS6296413A/en
Publication of JPH0742224B2 publication Critical patent/JPH0742224B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】 (イ)産業上の利用分野 本発明は酵素入り入浴剤の製造方法に関するものであ
る。
DETAILED DESCRIPTION OF THE INVENTION (a) Field of Industrial Application The present invention relates to a method for producing an enzyme-containing bath agent.

(ロ)従来技術 従来、酵素入り入浴剤の酵素としては、パパイン等植物
起源の蛋白分解酵素を単独で用いるものがある。かかる
入浴剤は、その含有する酵素成分によって、人体に付着
する蛋白を分解し、人体の清浄化を促進することができ
る。
(B) Conventional Technology Conventionally, as an enzyme of a bath agent containing an enzyme, there is one in which a proteolytic enzyme of plant origin such as papain is used alone. Such a bath agent is capable of degrading proteins adhering to the human body by the contained enzyme component and promoting cleaning of the human body.

(ハ)発明が解決しようとする問題点 しかし、かかる植物起源の蛋白分解酵素を単独で含有す
る入浴剤は、以下の点においていまだ問題を有してい
た。
(C) Problems to be Solved by the Invention However, such a bathing agent containing a proteolytic enzyme of plant origin alone still has problems in the following points.

単独の酵素のみでは、狭いpH域又は温度域でしか高
い蛋白質分解能を有することができず、水質によるpHの
相違又は使用時における温度の相違により皮膚の清浄化
が充分に行えない場合が生ずる。
A single enzyme alone can have a high protein decomposing ability only in a narrow pH range or temperature range, and the skin may not be sufficiently cleaned due to a difference in pH due to water quality or a difference in temperature during use.

そのため、白鮮菌等の温床となり易く、皮膚病の予防と
はなり得なかった。
Therefore, it is easy to become a hotbed of white bacterium and the like, and it cannot prevent skin diseases.

また、更に風呂の残り湯を洗濯水として用いる際に
は、比較的低い温度で使用されるために酵素の活性が低
く酵素による洗浄力強化が期待できなかった。
Further, when the remaining hot water in the bath is used as washing water, the activity of the enzyme is low because it is used at a relatively low temperature, and the enhancement of the detergency by the enzyme cannot be expected.

さらには、酵素自身の安定性もよくなく、酵素の経
時変化によって分解能力が低下し、所望の効果を発揮で
きないおそれがある。
Furthermore, the stability of the enzyme itself is not good, and the degradation ability of the enzyme may be deteriorated due to aging of the enzyme, and the desired effect may not be exhibited.

そこで、広いpH域及び温度域で酵素を作用させるため
に、微生物起源と、動物起源の異なる酵素を入浴剤中に
配合することが提案されている。またこのような酵素成
分等を入浴剤の基剤中において安定化させるために、生
薬を配合することも提案されている。しかしながら、2
種以上の酵素を配合し、且つ生薬を含有させた場合、個
々の酵素の安定化については改善されるものの、種類の
異なる酵素同士の反応による酵素活性低下の改善につい
ては十分とは言い難く、しかも生薬の配合を必須の構成
とする必要があるため、生薬を配合しない入浴剤への適
用が長期間保存における酵素活性の低下を鑑みた場合、
実質的に困難であるという欠点がある。
Therefore, in order to make the enzyme act in a wide pH range and temperature range, it has been proposed to mix enzymes of different microbial origin and animal origin in the bath salt. It has also been proposed to blend a crude drug in order to stabilize such enzyme components and the like in the base of the bath salt. However, 2
When blending more than one type of enzyme, and containing a crude drug, although the stabilization of each enzyme is improved, it is difficult to say that the reduction of enzyme activity due to the reaction between different types of enzymes is sufficient. Moreover, since it is necessary to make the composition of the crude drug an essential component, in consideration of the decrease in enzyme activity during long-term storage when applied to a bath agent containing no crude drug,
It has the drawback of being substantially difficult.

本発明は、このような従来の入浴剤が有する問題点を解
決することができる酵素配合入浴剤を提供することを目
的とする。
An object of the present invention is to provide an enzyme-containing bath agent that can solve the problems of such conventional bath agents.

(ニ)問題点を解決するための手段 本発明は、微生物起源の酵素と、動物起源の酵素と、植
物起源の酵素とからなる酵素成分を入浴剤基剤中に混合
するにあたり、酵素成分中の少なくとも2種以上を造粒
したことを特徴とする酵素入り入浴剤の製造方法に係る
ものである。
(D) Means for Solving the Problems In the present invention, in mixing an enzyme component consisting of an enzyme of microbial origin, an enzyme of animal origin, and an enzyme of plant origin into a bath salt base, The present invention relates to a method for producing an enzyme-containing bath salt, which comprises granulating at least two kinds of the above.

なお、ここで、微生物起源の酵素とは、枯草菌、麹菌、
放線菌などより得られる蛋白分解作用等を有する酵素を
いう。
Here, the enzymes of microbial origin are Bacillus subtilis, Aspergillus,
An enzyme having a proteolytic action and the like obtained from actinomycetes and the like.

また、動物起源の酵素とは、動物の臓器から抽出される
パンクレアチン、卵白から抽出されるリゾチウム又は塩
化リゾチウム等の蛋白分解作用、脂肪分解作用、澱粉分
解作用等を有する酵素をいう。
The enzyme of animal origin refers to an enzyme having a proteolytic action, a lipolytic action, a starch decomposing action, or the like, such as pancreatin extracted from animal organs, lysodium or lysodium chloride extracted from egg white.

さらに、植物起源の酵素とはパパイン、ブロメライン、
フィシン、または、大豆、麦芽などより得られる蛋白分
解作用、脂肪分解作用、澱粉分解作用等を有する酵素を
いう。
Furthermore, enzymes of plant origin are papain, bromelain,
Ficin, or an enzyme obtained from soybean, malt or the like, which has a proteolytic action, a lipolytic action, a starch decomposing action and the like.

本発明においては、前記各々の酵素の少なくとも2種以
上を造粒し、入浴剤基剤中における異なる種類の酵素同
士の反応等による著しい酵素活性の低下を防止する。
In the present invention, at least two or more of each of the above-mentioned enzymes are granulated to prevent a marked decrease in enzyme activity due to reaction between different types of enzymes in the bath agent base.

前記酵素の造粒化方法としては、各種形態が考えられ、
押出し造粒、転動式造粒、ブリケッティング等がある
が、酵素の造粒という観点からは、造粒工程による活性
の低下防止及び配合安定等を考慮して、押出し式による
造粒化方法が望ましい。
Various forms of the enzyme granulation method are possible,
Although there are extrusion granulation, tumbling granulation, briquetting, etc., from the viewpoint of enzyme granulation, the extrusion granulation is carried out in consideration of activity reduction prevention and formulation stability etc. in the granulation process. Method is preferred.

前記押出し造粒における顆粒の大量生産は、粉体→混合
→加水捏和→造粒→乾燥→整粒→篩別の工程で行う湿式
造粒法により行うことができる。
Mass production of granules in the extrusion granulation can be carried out by a wet granulation method which is carried out in the steps of powder → mixing → hydrogenation → granulation → drying → sizing → sieving.

前記造粒した酵素を入浴剤基剤に混合する際の配合割合
は、酵素以外の原料或いは、成分と視覚的に区別できる
のが好ましく、この観点から造粒化酵素の配合量は3重
量%以上とするのが望ましい。
The blending ratio when the granulated enzyme is mixed with the bathing agent base is preferably visually distinguishable from the raw materials other than the enzyme or the components. From this viewpoint, the blending amount of the granulated enzyme is 3% by weight. It is desirable to set it as above.

但し、酵素配合量の基本は、酵素作用の効果量及び安全
量であるため、入浴剤中の活性単位に基づく量でなけれ
ばならない。
However, since the basic amount of the enzyme is the effective amount of enzyme action and the safe amount, the amount must be based on the active unit in the bath agent.

また、前記造粒した酵素の粒度は、酵素以外の原料又は
成分の剤型と関連するので一概には決められないが、例
えば入浴剤の他の原料または成分を100メッシュとした
場合、10メッシュ程度とするのが好ましい。
Further, the particle size of the granulated enzyme cannot be unconditionally determined because it is related to the dosage form of the raw material or component other than the enzyme, but for example, when the other raw material or component of the bath agent is 100 mesh, 10 mesh It is preferably about the same.

また、上記微生物起源、動物起源及び植物起源の酵素
は、いずれも抗炎症作用も有する。
Further, all of the above-mentioned enzymes of microbial origin, animal origin and plant origin also have an anti-inflammatory action.

なお、本発明における基剤自体は、従来から入浴剤の基
剤として周知のものであり、塩化ナトリウム、炭酸水素
ナトリウム、ホウ砂、硫酸ナトリウム、セスキ炭酸ナト
リウム等の成分を適宜組み合わせて用いるものである。
The base itself in the present invention is well known as a base for bathing agents, and may be used by appropriately combining components such as sodium chloride, sodium hydrogen carbonate, borax, sodium sulfate and sodium sesquicarbonate. is there.

更に、コウボク,センキュウ,トウヒ,シャクヤク等の
生薬末やオオバクエキス等の生薬エキスを配合すること
もでき、生薬末や生薬エキスの配合により酵素及び色素
を経時的に安定化することができる。
Furthermore, crude drug powders such as Chinese cabbage, senkyu, spruce, and peony, and crude drug extracts such as psyllium extract can be blended, and by blending the crude drug powders and crude drug extracts, enzymes and pigments can be stabilized over time.

(ホ)作用及び効果 植物起源の酵素,微生物起源の酵素及び動物起源の酵素
は、それぞれpH及び温度に関する活性率において、最高
値を示す帯域を相違しているため、これらの協働によっ
て、かかる最高値を示す帯域を広くでき、水質の相違や
使用温度の相違にかかわらず、酵素による高い清浄化作
用を維持することができる。
(E) Action and effect Since the enzyme of plant origin, the enzyme of microbial origin and the enzyme of animal origin are different in the bands showing the highest values in the activity rates related to pH and temperature, respectively, the cooperation of these causes The band showing the maximum value can be widened, and the high cleaning action by the enzyme can be maintained regardless of the difference in water quality and the difference in operating temperature.

本発明の製造法では、前記植物起源の酵素、微生物起源
の酵素及び動物起源の酵素のうち少なくとも2種以上の
酵素を造粒化しているので、各々異なる起源の酵素同士
の接触反応による酵素活性の低下を防止することがで
き、前記作用効果を長期間維持することができる。
In the production method of the present invention, at least two kinds of enzymes of the above-mentioned plant-derived enzyme, microbial-derived enzyme and animal-derived enzyme are granulated. Can be prevented, and the above-mentioned effects can be maintained for a long period of time.

(ヘ)実施例 以下、本発明に係わる酵素入り入浴剤の製造方法を比較
例及び実施例に基づき詳説する。
(F) Example Hereinafter, the method for producing the bath salt containing an enzyme according to the present invention will be described in detail based on Comparative Examples and Examples.

〔第1比較例〕 まず、微生物起源の酵素であるASPプロテアーゼ(5万
単位/g)と、動物起源の酵素であるパンクレアチンと、
植物起源の酵素であるパパイン(3万単位/g)と、基剤
である塩化ナトリウム,ホウ砂,炭酸水素ナトリウムと
を撹拌・混合する。一方で、プロピレングリコール、色
素(青色1号),色素(黄色202号の(1))を撹拌・
混合する。
[First Comparative Example] First, ASP protease (50,000 units / g) that is an enzyme of microbial origin, and pancreatin that is an enzyme of animal origin,
Papain (30,000 units / g), which is an enzyme of plant origin, and the bases, sodium chloride, borax, and sodium hydrogen carbonate, are stirred and mixed. On the other hand, propylene glycol, dye (blue No. 1), dye (yellow No. 202 (1)) are stirred.
Mix.

その後、前者の撹拌混合物に後者の撹拌混合物及び香料
を加え、比較品1とする。
Then, the latter stirring mixture and the fragrance | flavor are added to the former stirring mixture, and it is set as the comparative product 1.

なお、配合割合を第1表に示す。The mixing ratio is shown in Table 1.

〔第1実施例〕 本実施例に係わる入浴剤は、酵素の安定化を図るため、
微生物起源の酵素,動物起源の酵素及び植物起源の酵素
の少なくともいずれかを造粒化したものであって、その
組成を発明品1〜4として第1表に示す。
[First Example] The bathing agent according to the present example is intended to stabilize the enzyme.
At least one of an enzyme of microbial origin, an enzyme of animal origin, and an enzyme of plant origin is granulated, and its composition is shown in Table 1 as invention products 1 to 4.

上記第1表において、比較品1は、微生物起源の酵素,
植物起源の酵素及び動物起源の酵素のいずれもが造粒化
されていない場合であり、発明品1は動物起源の酵素と
植物起源の酵素が造粒化されている場合であり、発明品
2は植物起源の酵素と微生物起源の酵素が造粒化されて
いる場合であり、発明品3は、微生物起源の酵素、動物
起源の酵素が造粒化されている場合であり、発明品4
は、微生物起源の酵素と、動物起源の酵素及び植物起源
の酵素のいずれもが造粒化されている場合である。
In Table 1 above, Comparative product 1 is an enzyme of microbial origin,
Inventive product 1 is a case where neither a plant-derived enzyme nor an animal-derived enzyme is granulated, and Invention 1 is a case where an animal-derived enzyme and a plant-derived enzyme are granulated. The case where the enzyme of plant origin and the enzyme of microbial origin are granulated, the invention product 3 is the case where the enzyme of microbial origin and the enzyme of animal origin are granulated, and the invention product 4 is
Is the case where both the enzyme of microbial origin, the enzyme of animal origin and the enzyme of plant origin are granulated.

かかる入浴剤(発明品1〜4)も、第1比較例と同様な
工程で製造するものである。
Such bath agents (invention products 1 to 4) are also manufactured by the same steps as in the first comparative example.

また、上記比較品1,発明品1〜4内に含有する酵素の残
存活性率を、恒温室ではない室内における室温(20℃〜
27℃)と保存温度40℃とした場合について調べ、その結
果を第1図及び第2図のグラフに示す。
In addition, the residual activity ratios of the enzymes contained in the comparative product 1 and the invention products 1 to 4 were measured at room temperature (20 ° C to
27 ° C.) and storage temperature 40 ° C. were investigated, and the results are shown in the graphs of FIGS. 1 and 2.

第1図から明らかなように、室温保存では、100日経過
した時点で、微生物起源の酵素,動物起源及び植物起源
の酵素のいずれも造粒化していない入浴剤(比較品1)
が、6%の残存活性率しか示していないのに対して、動
物起源の酵素及び植物酵素の酵素を造粒化したもの(発
明品1)、微生物起源の酵素及び植物酵素の酵素を造粒
化したもの(発明品2)、微生物起源の酵素及び動物起
源の酵素を造粒化したもの(発明品3)は、それぞれ、
62%、44%及び29%の残存活性率を示しており、さらに
全ての含有酵素を造粒化したもの(発明品4)は、94%
の残存活性率を示している。
As is clear from FIG. 1, after 100 days of storage at room temperature, no bath-forming agent (comparative product 1) has been granulated with any enzyme of microbial origin, animal origin or plant origin.
Shows a residual activity rate of only 6%, whereas the enzyme of animal origin and the enzyme of plant enzyme are granulated (Invention 1), the enzyme of microbial origin and the enzyme of plant enzyme are granulated. The product (invention product 2), the enzyme of microbial origin and the enzyme of animal origin are granulated (invention product 3), respectively.
The residual activity rates of 62%, 44% and 29% are shown, and 94% is obtained by granulating all the contained enzymes (Invention product 4).
Shows the residual activity rate of.

第2図から明らかなように、40℃保存では、70日経過し
た時点で、微生物起源の酵素,動物起源及び植物起源の
酵素のいずれも造粒化していない入浴剤(比較品1)の
残存活性率が零になっているのに対して、動物起源の酵
素及び植物酵素の酵素を造粒化したもの(発明品1)、
微生物起源の酵素及び植物起源の酵素を造粒化したもの
(発明品2)、微生物起源の酵素及び動物起源の酵素を
造粒化したもの(発明品3)は、それぞれ、100日経過
した時点で、37%、19%及び0%の残存活性率を示して
おり、さらに全ての含有酵素を造粒化したもの(発明品
4)は、56%の残存活性率を示している。
As is clear from FIG. 2, after 40 days of storage, the bath agent (Comparative Product 1) which had not granulated any of the enzyme of microbial origin, enzyme of animal origin and enzyme of plant origin remained at 70 days after storage. Where the activity rate is zero, the enzyme of animal origin and the enzyme of plant enzyme are granulated (invention product 1),
Granules of microorganism-derived enzyme and plant-derived enzyme (Invention Product 2) and granules of microbial-derived enzyme and animal-origin enzyme (Invention Product 3) were measured after 100 days had passed. The residual activity rates of 37%, 19% and 0% are shown, and the granulation of all the contained enzymes (Invention product 4) shows the residual activity rate of 56%.

このように、本発明品は、少なくとも二種類の酵素を造
粒化させることによって、室温及び40℃のいずれにおい
ても、酵素の高い活性を保持することができる。
As described above, the product of the present invention can retain high enzyme activity at both room temperature and 40 ° C. by granulating at least two kinds of enzymes.

〔第2実施例及び第2比較例〕 第1実施例と同様な造粒化による酵素の安定化試験を、
微生物起源の酵素として放線菌プロテアーゼ(5万単位
/g)を、動物起源の酵素としてパンクレアチンを、植物
起源の酵素としてブロメライン(3万単位/g)を、混合
した入浴剤(発明品2,7〜10)について行った。
[Second Example and Second Comparative Example] The same enzyme stabilization test by granulation as in the first example was conducted.
Actinomycetes protease as an enzyme of microbial origin (50,000 units
/ g), pancreatin as an enzyme of animal origin and bromelain (30,000 units / g) as an enzyme of plant origin were mixed with a bath agent (invention products 2, 7 to 10).

かかる入浴剤の成分構成を第2表に示すとともに、第3
図及び第4図に試験結果を示す。
The composition of components of such a bath agent is shown in Table 2 and
The test results are shown in FIGS.

なお、第2表中の比較品2は、いずれの酵素も造粒化し
ていない比較品である。
The comparative product 2 in Table 2 is a comparative product in which neither enzyme was granulated.

第3図及び第4図から明らかなように、本実施例も、植
物起源、微生物起源又は動物起源の酵素の少なくともい
ずれかの酵素を造粒化させることによって、室温及び40
℃のいずれにおいても、酵素の高い活性を保持すること
ができることを示している。
As is clear from FIG. 3 and FIG. 4, this example also shows that at room temperature and 40 ° C. by granulating at least one enzyme of plant, microbial or animal origin.
It is shown that the high activity of the enzyme can be retained at any of the temperatures.

〔第3実施例及び第3比較例〕 また、比較品1、発明品1〜4については、さらに含有
する酵素量を測定した。
[Third Example and Third Comparative Example] Further, with respect to Comparative Product 1 and Invention Products 1 to 4, the amount of enzyme further contained was measured.

なお、測定法は、チロジン−フオリン法を用い、1分間
に1μgのチロジン相当量フオリン呈色を1プロテアー
ゼ単位とした。
The tyrosin-fluorin method was used as the measuring method, and 1 μg of thyrozine equivalent amount of phosphorin per minute was defined as 1 protease unit.

その結果を第3表に示す。The results are shown in Table 3.

第3表から明らかなように、全ての酵素成分を造粒化し
ていない比較品1については、合計力価のみが測定でき
たが、どのような酵素がどの位の活性量含有されている
かについては測定できなかった。
As is clear from Table 3, only the total titer could be measured for Comparative Product 1 in which all enzyme components were not granulated, but what kind of enzyme and what amount of active amount were contained Could not be measured.

即ち、比較品1については、分離定量が不可能であっ
た。
That is, it was impossible to separate and quantify the comparative product 1.

これに対して、発明品1〜4については、それぞれ微生
物起源、動物起源及び植物起源の酵素をどれだけ含有す
るかの分離定量を正確に行うことができた。
On the other hand, with regard to the invention products 1 to 4, it was possible to accurately separate and quantify the amount of the enzyme of microbial origin, animal origin and plant origin, respectively.

これによって、複数の酵素が含有されていること、及び
それらの活性量が幾らであるか明示することができ、使
用者に安心感を与えることができる。
This makes it possible to clearly indicate that a plurality of enzymes are contained and how much their active amount is, and it is possible to give the user a sense of security.

〔第4実施例及び第4比較例〕 第3実施例における酵素量の測定を、第2実施例及び第
2比較例おける比較品2及び発明品5〜8についても行
い、その結果を第4表に示す。
[Fourth Example and Fourth Comparative Example] The amount of enzyme in the third example was also measured for Comparative Product 2 and Invention Products 5 to 8 in the second Example and the second Comparative Example, and the results were evaluated as the fourth result. Shown in the table.

本実施例も、本発明にかかる入浴剤には、複数の酵素が
含有されていること、及びそれらの活性量がいくらであ
るか明示することができ、使用者に安心感を与えること
ができる。
Also in this example, it is possible to clearly show that the bathing agent according to the present invention contains a plurality of enzymes and how much their active amounts are, thus giving the user a sense of security. .

【図面の簡単な説明】[Brief description of drawings]

第1図及び第2図は、第1実施例及び第1比較例の室温
及び40℃における同入浴剤の残存活性率を示すグラフ、
第3図及び第4図は、第2実施例及び第2比較例の室温
及び40℃における同入浴剤の残存活性率を示すグラフで
ある。
FIG. 1 and FIG. 2 are graphs showing the residual activity rates of the bath salts at room temperature and 40 ° C. of the first example and the first comparative example,
FIG. 3 and FIG. 4 are graphs showing the residual activity ratios of the bath agents at room temperature and 40 ° C. of the second example and the second comparative example.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】微生物起源の酵素と、動物起源の酵素と、
植物起源の酵素とからなる酵素成分を入浴剤基剤中に混
合するにあたり、酵素成分中の少なくとも2種以上を造
粒したことを特徴とする酵素入り入浴剤の製造方法。
1. An enzyme of microbial origin and an enzyme of animal origin,
A method for producing an enzyme-containing bath agent, which comprises granulating at least two or more of the enzyme components in mixing an enzyme component comprising an enzyme of plant origin with a bath agent base.
JP60237872A 1985-10-23 1985-10-23 Method for producing bath salt containing enzyme Expired - Fee Related JPH0742224B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60237872A JPH0742224B2 (en) 1985-10-23 1985-10-23 Method for producing bath salt containing enzyme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60237872A JPH0742224B2 (en) 1985-10-23 1985-10-23 Method for producing bath salt containing enzyme

Publications (2)

Publication Number Publication Date
JPS6296413A JPS6296413A (en) 1987-05-02
JPH0742224B2 true JPH0742224B2 (en) 1995-05-10

Family

ID=17021662

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60237872A Expired - Fee Related JPH0742224B2 (en) 1985-10-23 1985-10-23 Method for producing bath salt containing enzyme

Country Status (1)

Country Link
JP (1) JPH0742224B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100558183B1 (en) * 1999-04-22 2006-03-10 주식회사 엘지생활건강 Composition of personal care-product comprising enzyme

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50111226A (en) * 1974-02-14 1975-09-01
JPS60109518A (en) * 1983-11-16 1985-06-15 Tadao Shiraishi Production of bath agent containing enzyme

Also Published As

Publication number Publication date
JPS6296413A (en) 1987-05-02

Similar Documents

Publication Publication Date Title
DE3141745C2 (en)
JPS61286319A (en) Production of bathing agent
DE60117026T2 (en) IMPROVEMENTS IN TABLETS IN ENZYMES
JPS6324973B2 (en)
JPH0742224B2 (en) Method for producing bath salt containing enzyme
EP0185528A2 (en) Enzymatic drain cleaning compositions
JPH0742222B2 (en) Method for producing bath salt containing enzyme
JPS5923754B2 (en) granular face wash
JPH0742223B2 (en) Method for producing bath salt containing enzyme
JPH0454645B2 (en)
DE1617190A1 (en) Coarse detergent containing enzymes
JPH0745398B2 (en) Method for producing enzyme-containing facial cleansing powder
JPH048288A (en) Production of enzyme-containing readily disintegrable tablet
JPH0745399B2 (en) Method for producing enzyme-containing facial cleansing powder
JPS6299321A (en) Production of face washing powder containing enzyme
JPH0745397B2 (en) Method for producing enzyme-containing facial cleansing powder
JPS5923753B2 (en) powdered face wash
JP2523319B2 (en) Enzyme bath
JPS58105910A (en) Solid bath composition
JP2574738B2 (en) Enzyme-encapsulated wax capsule
JPS6324972B2 (en)
JPH09249529A (en) Wax capsule and cleaning material composition
JPS62269685A (en) Enzymic granule
JPH0222219A (en) Production of enzyme-containing bathing agent
JPH06239733A (en) Facial cleansing agent

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees